Morgan Stanley raises target for CSL stock from AUD 182.00 to AUD 200.00

Published on 10/20/2026 at 10:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

CSL's annual meeting is set for October 27, 2026. CSL stock costs EUR 120.92 on October 20, 2026 while Morgan Stanley targets AUD 200.00.

Targets, meeting and market value

Morgan Stanley lifted its CSL target from AUD 182.00 to AUD 200.00 on October 20, 2026.
CSL's annual meeting is scheduled for October 27, 2026.
CSL stock trades at EUR 120.92 at 10:16 a.m. CEST at Lang & Schwarz on October 20, 2026.

CSL, AU000000CSL8, Illustration mit AI erstellt.

CSL (ISIN AU000000CSL8) was trading at EUR 120.92 at Lang & Schwarz on October 20, 2026 at 10:16 a.m. CEST. The Motley Fool reported on October 20, 2026 that Morgan Stanley raised its CSL target from AUD 182.00 to AUD 200.00.

Why the target moved higher

Morgan Stanley tied the revised valuation to two development agreements involving Varm-X and Alentis. The broker's model assigns AUD 8.00 per share to VMX-C001 and AUD 3.00 per share to lixudebart, according to the October 20, 2026 report.

The same report says the compounds could add 2.00 percent to earnings per share assumptions in fiscal year 2032 and 7.00 percent by fiscal year 2036. Morgan Stanley also applies a 20.60 times multiple to its 12-month forward underlying earnings-per-share forecast.

Three dates frame the reset

On August 31, 2026, CSL announced a USD 1.5 billion plan to expand US manufacturing capacity. On October 5, 2026, CSL and Alentis announced a partnership with a USD 355 million initial payment and up to USD 1.2 billion in commercial milestones. On October 20, 2026, Morgan Stanley lifted its target to AUD 200.00.

What does the target mean for CSL?

The revised target places the emphasis on execution rather than a single product launch. CSL reported fiscal-year 2026 revenue of USD 15.8 billion and underlying net profit after tax of USD 3.1 billion, with the latter down 2.00 percent, according to Veye on October 15, 2026. The company guided to underlying net profit growth of 5.00 percent for fiscal year 2027 while expecting broadly flat revenue.

AGM arrives before half-year results

CSL's annual meeting is scheduled for October 27, 2026, according to the company's investor-relations page. The next half-year results are scheduled for February 10, 2027, as reported by Veye on October 15, 2026.

Market value remains substantial

CSL had a market capitalization of AUD 94.2 billion on October 20, 2026. Its 52-week range was AUD 90.00 to AUD 221.76, leaving the current ASX quotation below the yearly high while the European indication stood at EUR 120.92.

The stock was trading at EUR 120.92 at Lang & Schwarz on October 20, 2026 at 10:16 a.m. CEST. The further course of trading is shown by the continuously updated real-time quote of CSL stock.